(Q38413380)

2 September 2017

title

A three-way interplay of DR4, autoantibodies and synovitis in biopsy-proven idiopathic inflammatory myositis (English)

1 reference

2 September 2017

1 reference

Vidya S Limaye

1

1 reference

2 September 2017

Sue Lester

2

1 reference

2 September 2017

Peter Bardy

3

1 reference

2 September 2017

Philip Thompson

4

1 reference

2 September 2017

Sally Cox

5

1 reference

2 September 2017

Peter Blumbergs

6

1 reference

2 September 2017

Peter Roberts-Thomson

7

1 reference

2 September 2017

publication date

2 December 2010

1 reference

Rheumatology International

2 September 2017

published in

1 reference

2 September 2017

volume

32

1 reference

2 September 2017

issue

3

1 reference

2 September 2017

page(s)

611-619

1 reference

Idiopathic inflammatory myopathies: epidemiology, classification, and diagnostic criteria

2 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00296-010-1637-5

Polymyositis, dermatomyositis and inclusion-body myositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-010-1637-5

Polymyositis and dermatomyositis (first of two parts)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-010-1637-5

Novel classification of idiopathic inflammatory myopathies based on overlap syndrome features and autoantibodies: analysis of 100 French Canadian patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-010-1637-5

Differences in idiopathic inflammatory myopathy phenotypes and genotypes between Mesoamerican Mestizos and North American Caucasians: ethnogeographic influences in the genetics and clinical expression of myositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-010-1637-5

Have recent immunogenetic investigations increased our understanding of disease mechanisms in the idiopathic inflammatory myopathies?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-010-1637-5

HLA associations with inclusion body myositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-010-1637-5

Pathogenesis of autoimmune diseases associated with 8.1 ancestral haplotype: effect of multiple gene interactions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-010-1637-5

Clinical implications of autoantibody screening in patients with autoimmune myositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-010-1637-5

Heterogeneity of autoantibodies in 100 patients with autoimmune myositis: insights into clinical features and outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-010-1637-5

Newly identified autoantibodies: relationship to idiopathic inflammatory myopathy subsets and pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-010-1637-5

Clinical and immunogenetic features of patients with autoantibodies to asparaginyl-transfer RNA synthetase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-010-1637-5

TRIM21 is a trimeric protein that binds IgG Fc via the B30.2 domain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-010-1637-5

Immunogenetic risk and protective factors for the idiopathic inflammatory myopathies: distinct HLA-A, -B, -Cw, -DRB1, and -DQA1 allelic profiles distinguish European American patients with different myositis autoantibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-010-1637-5

Interrelationship of major histocompatibility complex class II alleles and autoantibodies in four ethnic groups with various forms of myositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-010-1637-5

Clinical and human leucocyte antigen class II haplotype associations of autoantibodies to small ubiquitin-like modifier enzyme, a dermatomyositis-specific autoantigen target, in UK Caucasian adult-onset myositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-010-1637-5

Myositis-specific and myositis-associated antibodies in a series of eighty-eight Mediterranean patients with idiopathic inflammatory myopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-010-1637-5

Score tests for association between traits and haplotypes when linkage phase is ambiguous

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-010-1637-5

Two major histocompatibility complex haplotypes influence susceptibility to sporadic inclusion body myositis: critical evaluation of an association with HLA-DR3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-010-1637-5

The genetic basis for the association of the 8.1 ancestral haplotype (A1, B8, DR3) with multiple immunopathological diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-010-1637-5

Genetics of the central MHC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-010-1637-5

TNF2, a polymorphism of the tumour necrosis-alpha gene promoter, is a component of the celiac disease major histocompatibility complex haplotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-010-1637-5

A genetically determined high setting of TNF-alpha influences immunologic parameters of HLA-B8,DR3 positive subjects: implications for autoimmunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-010-1637-5

Inclusion body myositis in connective tissue disorders: case report and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-010-1637-5

Mechanisms of disease: autoantigens as clues to the pathogenesis of myositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-010-1637-5

Use of a commercial line blot assay as a screening test for autoantibodies in inflammatory myopathies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-010-1637-5

Idiopathic inflammatory myopathies

21 January 2018

1 reference

12 December 2020

Analysis of HLA class I and II alleles in sporadic inclusion-body myositis

1 reference

12 December 2020

Unusually high frequency of autoantibodies to PL-7 associated with milder muscle disease in Japanese patients with polymyositis/dermatomyositis

1 reference

12 December 2020

Tumour necrosis factor-alpha single nucleotide polymorphisms are not independent of HLA class I in UK Caucasians with adult onset idiopathic inflammatory myopathies

1 reference

12 December 2020

Immunogenetics of inflammatory myopathies.

1 reference

12 December 2020

Autoantibodies in myositis.

1 reference

12 December 2020

Strong association of dermatomyositis-specific Mi-2 autoantibodies with a tryptophan at position 9 of the HLA-DR beta chain

1 reference

12 December 2020

Humoral immunity in polymyositis/dermatomyositis

1 reference

12 December 2020

Associations between serum anti-CCP antibody, rheumatoid factor levels and HLA-DR4 expression in Hungarian patients with rheumatoid arthritis

1 reference

12 December 2020

Computer-assisted analysis of 153 patients with polymyositis and dermatomyositis

1 reference

12 December 2020

Ancestral haplotypes reveal the role of the central MHC in the immunogenetics of IDDM

1 reference

12 December 2020

Rearrangement of 21-hydroxylase genes in disease-associated MHC supratypes

1 reference

12 December 2020

Redefining the HLA and RA association: to be or not to be anti-CCP positive.

1 reference

12 December 2020

Associations with autoimmune disorders and HLA class I and II antigens in inclusion body myositis

1 reference

12 December 2020

A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups

1 reference

12 December 2020

Inflammatory muscle diseases

1 reference

12 December 2020

Anti-Ro52 antibodies frequently co-occur with anti-Jo-1 antibodies in sera from patients with idiopathic inflammatory myopathy

1 reference

12 December 2020

10.1007/S00296-010-1637-5

Identifiers

DOI

1 reference

Dimensions Publication ID

2 September 2017

1028948157

0 references

1 reference